<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04197206</url>
  </required_header>
  <id_info>
    <org_study_id>CTB in Breast surgery</org_study_id>
    <nct_id>NCT04197206</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Costotransverse Block for Breast Cancer Surgery</brief_title>
  <official_title>Evaluation of Ultrasound Guided Costotransverse Block in Breast Canser Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cigli Regional Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cigli Regional Training Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Costotransverse block is a novel regional anesthesia technique described a few months ago.
      It's use for breast surgery has been reported by only one case report in the literature. As
      the investigators have considered that Costotransverse block can be efficacious for providing
      postoperative analgesia in the breast surgeries, the investigators have implemented the
      application of this blockade into practice at the clinic. The main purpose of this study is
      to evaluate the analgesic effect of ultrasound-guided unilateral costotransverse block in
      breast cancer surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Actual">April 29, 2020</completion_date>
  <primary_completion_date type="Actual">April 29, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24 hours morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>morphine consumptions for both group will be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric rating scale for postoperative pain intensity</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in Numeric Rating Scale (NRS) at rest and on movement will be recorded at intervals. NRS is a unidimensional measure of pain intensity in adults. The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. &quot;no pain&quot;) to '10' representing the other pain extreme (e.g. &quot;pain as bad as you can imagine&quot; or &quot;worst pain imaginable&quot;).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Costotransverse block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Costotransverse block will be administrated to this group before induction of anesthesia. An intravenous patient-controlled analgesia device within morphine will be given to the patients postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In this group, patients will receive only multimodal analgesic treatment including patient-controlled analgesia with morphine. No block will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>costotransverse block</intervention_name>
    <description>patient controlled analgesia devices with tramadol</description>
    <arm_group_label>Costotransverse block</arm_group_label>
    <other_name>patient controlled analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing breast canser surgery under general anesthesia ASA I-II

        Exclusion Criteria:

          -  patients undergoing breast surgery under paravertebral block and others morbidly
             obesity ASA III - IV infection of the skin at the site of needle puncture area
             patients with known allergies to any of the study drugs coagulopathy recent use of
             analgesic/steroid drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cigli regional research hospital</name>
      <address>
        <city>İzmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Aygun H, Thomas DT, Nart A. Ultrasound guided single injection costotransverse block in a breast conserving surgery patient; The first clinical report for novel interfascial block. J Clin Anesth. 2020 May;61:109647. doi: 10.1016/j.jclinane.2019.109647. Epub 2019 Oct 26.</citation>
    <PMID>31662230</PMID>
  </results_reference>
  <results_reference>
    <citation>Nielsen MV, Moriggl B, Hoermann R, Nielsen TD, Bendtsen TF, Børglum J. Are single-injection erector spinae plane block and multiple-injection costotransverse block equivalent to thoracic paravertebral block? Acta Anaesthesiol Scand. 2019 Oct;63(9):1231-1238. doi: 10.1111/aas.13424. Epub 2019 Jul 23.</citation>
    <PMID>31332775</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cigli Regional Training Hospital</investigator_affiliation>
    <investigator_full_name>Hakan Aygün</investigator_full_name>
    <investigator_title>Principal Investigator,</investigator_title>
  </responsible_party>
  <keyword>ultrasound guided block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

